CME Group Achieves $1.2 Billion Revenue in Q2 2022

One of the well-known derivatives marketplaces in the world, CME Group today reported financial results for the second quarter of 2022. During the reported period, CME Group posted revenue of $1.2 billion and operating income of $750 million.

During the recent quarter, CME Group's net income was $663 million and diluted earnings per share were $1.82. On an adjusted basis, net income was $717 million and diluted earnings per share were $1.97.

As reported earlier this month, the group's average daily volume (ADV) was 23.1 million contracts, including non-U.S. ADV of 6.3 million contracts, led by 40% growth in Latin America, 36% in Asia and 15% in EMEA.

Clearing and transaction fees revenue for second-quarter 2022 totaled $1.0 billion. The total average rate per contract was $0.647. Market data revenue totaled $152 million for second-quarter 2022.

"As global market participants continued to navigate extraordinary economic and geopolitical uncertainties throughout the second quarter, demand for CME Group hedging tools drove our strong earnings and revenue growth, with our equity index, interest rate, foreign exchange and options volumes rising in the U.S. and internationally,"said CME Group Chairman and Chief Executive Officer Terry Duffy.

"We reached our third highest quarterly average daily volume on record in Q2, and, in particular, our SOFR futures and options contracts reached new records in both volume and open interest, driven by the industry's accelerating transition away from USD LIBOR. Additionally, market users increasingly turned to our micro and E-mini contracts to customize their trading strategies. Moving forward, we will remain focused on providing our clients with the tools they need to manage risk amid central bank tightening, historic inflation and other challenging market conditions."